About Embryo Options
Embryo Options is a company based in Round Hill (United States) founded in 2009 was acquired by CooperSurgical in January 2021. Embryo Options offers products and services including Paragard, Endosee Advance System, RUMI II, and Lone Star. Embryo Options operates in a competitive market with competitors including Trellis Rx, Higgs Boson Health, MedCenterDisplay, PlatformQ and EASE Applications, among others.
- Headquarter Round Hill, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Coopersurgical, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
CooperSurgical
(Jan 05, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Embryo Options
Embryo Options offers a comprehensive portfolio of products and services, including Paragard, Endosee Advance System, RUMI II, and Lone Star.
Intrauterine device for effective long-term birth control.
Hysteroscopy tool for office-based uterine examinations.
Manipulator for uterine positioning during procedures.
Retractor system for enhanced visibility in surgeries.
Funding Insights of Embryo Options
Investors in Embryo Options
Embryo Options has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include CooperSurgical.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Offers medical devices for fertility, contraception, and women's health care globally.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Embryo Options
Financial Statements - Embryo Options
Embryo Options Comparisons
Competitors of Embryo Options
Embryo Options operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Trellis Rx, Higgs Boson Health, MedCenterDisplay, PlatformQ and EASE Applications, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Patient engagement solutions are offered for hospitals and pharmacies.
|
|
| domain | founded_year | HQ Location |
Provider an app for surgical management
|
|
| domain | founded_year | HQ Location |
Patient engagement solutions for healthcare facilities
|
|
| domain | founded_year | HQ Location |
Enrollment management software is provided for higher education institutes.
|
|
| domain | founded_year | HQ Location |
HIPAA-compliant messaging for real-time patient status updates is provided.
|
|
| domain | founded_year | HQ Location |
Digital therapeutic solutions are provided for pain and anxiety management.
|
Latest news on Embryo Options
Frequently Asked Questions about Embryo Options
Embryo Options was founded in 2009.
Embryo Options is headquartered in Round Hill, United States. It is registered at Round Hill, Virginia, United States.
Embryo Options was founded in 2009 and is based in Round Hill, United States. An online platform is operated in the fertility sector to educate IVF patients on options for cryopreserved embryos, eggs, and sperm. Access to learning materials and decision-support tools is granted through the portal, along with secure online payment for cryopreservation storage fees. The service functions as a comprehensive educational resource for fertility patients.
Embryo Options's top competitors include PlatformQ, Higgs Boson Health and Trellis Rx.
Embryo Options offers Paragard, Endosee Advance System, RUMI II, and Lone Star.
Embryo Options has 1 investor. Key investors include CooperSurgical.